Company profile CGTX

Cognition Therapeutics Inc
cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.
Quarter analysis & expected interest

There is not enough data for cognition therapeutics login to provide analysis

Correlation between past revenue and cognition therapeutics login search interest

There is not enough data for cognition therapeutics login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 16:46:17.

After 39 days of this quarter the interest is at 99.0. Based on that we can calculate that during remaining 52 days it will total up to 231.0.
cognition therapeutics stock expected interest is significantly higher compared to previous quarter (+108.1%) and same quarter last year (+904.3%).

YearQ1Q2Q3Q4
20190
28
inf% QoQ
25
-10.7% QoQ
58
132.0% QoQ
2020 187
inf% YoY 222.4% QoQ
116
314.3% YoY -38.0% QoQ
50
100.0% YoY -56.9% QoQ
80
37.9% YoY 60.0% QoQ
2021 56
-70.1% YoY -30.0% QoQ
0
-100.0% YoY -100.0% QoQ
59
18.0% YoY inf% QoQ
50
-37.5% YoY -15.3% QoQ
2022 60
7.1% YoY 20.0% QoQ
60
inf% YoY 0.0% QoQ
278
371.2% YoY 363.3% QoQ
124
148.0% YoY -55.4% QoQ
2023 23
-61.7% YoY -81.5% QoQ
90
50.0% YoY 291.3% QoQ
165
-40.6% YoY 83.3% QoQ
111
-10.5% YoY -32.7% QoQ
2024 99
330.4% YoY -10.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and cognition therapeutics stock search interestLast update: February 09 2024 16:46:15.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 16:46:18.

The average 5 years interest of cognition therapeutics stock was 6.59 per week.
The last year interest of cognition therapeutics stock compared to the last 5 years has changed by 35.66%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 162.94%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics careers to provide analysis

Correlation between past revenue and cognition therapeutics careers search interest

There is not enough data for cognition therapeutics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics news to provide analysis

Correlation between past revenue and cognition therapeutics news search interest

There is not enough data for cognition therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics CT1812 to provide analysis

Correlation between past revenue and cognition therapeutics CT1812 search interest

There is not enough data for cognition therapeutics CT1812 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics CT1812 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics Alzheimer's disease to provide analysis

Correlation between past revenue and cognition therapeutics Alzheimer's disease search interest

There is not enough data for cognition therapeutics Alzheimer's disease to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics Alzheimer's disease to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics clinical trials to provide analysis

Correlation between past revenue and cognition therapeutics clinical trials search interest

There is not enough data for cognition therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics CT0201 SHINE to provide analysis

Correlation between past revenue and cognition therapeutics CT0201 SHINE search interest

There is not enough data for cognition therapeutics CT0201 SHINE to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics CT0201 SHINE to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics CT2168 to provide analysis

Correlation between past revenue and cognition therapeutics CT2168 search interest

There is not enough data for cognition therapeutics CT2168 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics CT2168 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cognition therapeutics CT2074 to provide analysis

Correlation between past revenue and cognition therapeutics CT2074 search interest

There is not enough data for cognition therapeutics CT2074 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cognition therapeutics CT2074 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CGTX
Earnings date: 2024-03-23 After close
Company name: Cognition Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T11:30:00Z

GlobeNewswire
Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

2026-05-07T20:15:00Z

GlobeNewswire
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update

2026-04-07T11:30:00Z

GlobeNewswire
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference

2026-03-31T20:30:00Z

GlobeNewswire
Cognition Therapeutics CEO Issues Letter to Shareholders

2026-03-26T11:30:00Z

GlobeNewswire
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

2026-03-23T11:30:00Z

GlobeNewswire
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

2026-03-02T12:30:00Z

GlobeNewswire
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis

2026-02-05T12:30:00Z

GlobeNewswire
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

2026-01-27T12:30:00Z

GlobeNewswire
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies

2025-12-04T11:15:32Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

2025-12-03T12:30:00Z

GlobeNewswire
Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

2025-12-01T12:30:00Z

GlobeNewswire
Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer's Disease at Clinical Trials on Alzheimer's Disease (CTAD) Conference

2025-11-21T16:10:59Z

Analyst Upgrades
B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3

2025-11-20T21:01:00Z

GlobeNewswire
Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference

2025-11-19T11:55:08Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target